Maddalena Ferranna

Title(s)Assistant Professor of the Department of Pharmaceutical and Health Economics
SchoolUSC School of Pharmacy
Address635 Downey Way
University Park Campus
Los Angeles CA 90089
Phone+1 323 442 0599
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The full health, economic, and social benefits of prospective Strep A vaccination. NPJ Vaccines. 2023 Oct 30; 8(1):166. Cadarette D, Ferranna M, Cannon JW, Abbas K, Giannini F, Zucker L, Bloom DE. PMID: 37903813; PMCID: PMC10616198.
      View in: PubMed   Mentions: 4  
    2. Causes and costs of global COVID-19 vaccine inequity. Semin Immunopathol. 2024 Jan; 45(4-6):469-480. Ferranna M. PMID: 37870569; PMCID: PMC11136847.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    3. The macroeconomic burden of noncommunicable diseases and mental health conditions in South America. PLoS One. 2023; 18(10):e0293144. Ferranna M, Cadarette D, Chen S, Ghazi P, Ross F, Zucker L, Bloom DE. PMID: 37862345; PMCID: PMC10588886.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Optimal global spending for group A Streptococcus vaccine research and development. NPJ Vaccines. 2023 Apr 25; 8(1):62. Tortorice D, Ferranna M, Bloom DE. PMID: 37185380; PMCID: PMC10125865.
      View in: PubMed   Mentions: 3  
    5. The benefits and costs of U.S. employer COVID-19 vaccine mandates. Risk Anal. 2023 10; 43(10):2053-2068. Ferranna M, Robinson LA, Cadarette D, Eber MR, Bloom DE. PMID: 36649917.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    6. Factors underlying COVID-19 vaccine and booster hesitancy and refusal, and incentivizing vaccine adoption. PLoS One. 2022; 17(9):e0274529. Bennett NG, Bloom DE, Ferranna M. PMID: 36136997; PMCID: PMC9498968.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    7. Correction: Social determinants of mortality from COVID-19: A simulation study using NHANES. PLoS Med. 2021 Dec; 18(12):e1003888. Seligman B, Ferranna M, Bloom DE. PMID: 34965261; PMCID: PMC8716040.
      View in: PubMed   Mentions:    Fields:    
    8. Climate action with revenue recycling has benefits for poverty, inequality and well-being. Nat Clim Chang. 2021 Dec; 11(12):1111-1116. Budolfson M, Dennig F, Errickson F, Feindt S, Ferranna M, Fleurbaey M, Klenert D, Kornek U, Kuruc K, Méjean A, Peng W, Scovronick N, Spears D, Wagner F, Zuber S. PMID: 39006801; PMCID: PMC11244949.
      View in: PubMed   Mentions: 5  
    9. COVID-19 Vaccine Allocation: Modeling Health Outcomes and Equity Implications of Alternative Strategies. Engineering (Beijing). 2021 Jul; 7(7):924-935. Ferranna M, Cadarette D, Bloom DE. PMID: 33968462; PMCID: PMC8089031.
      View in: PubMed   Mentions: 15  
    10. The Societal Value of Vaccination in the Age of COVID-19. Am J Public Health. 2021 06; 111(6):1049-1054. Bloom DE, Cadarette D, Ferranna M. PMID: 33856880; PMCID: PMC8101582.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic Health
    11. How New Models Of Vaccine Development For COVID-19 Have Helped Address An Epic Public Health Crisis. Health Aff (Millwood). 2021 03; 40(3):410-418. Bloom DE, Cadarette D, Ferranna M, Hyer RN, Tortorice DL. PMID: 33539191.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    12. Social determinants of mortality from COVID-19: A simulation study using NHANES. PLoS Med. 2021 01; 18(1):e1003490. Seligman B, Ferranna M, Bloom DE. PMID: 33428624; PMCID: PMC7799807.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCellsPHPublic Health
    13. Valuing Health Impacts In Climate Policy: Ethical Issues And Economic Challenges. Health Aff (Millwood). 2020 12; 39(12):2105-2112. Scovronick N, Ferranna M, Dennig F, Budolfson M. PMID: 33284691; PMCID: PMC7891186.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Fair innings? The utilitarian and prioritarian value of risk reduction over a whole lifetime. J Health Econ. 2021 01; 75:102412. Adler MD, Ferranna M, Hammitt JK, Treich N. PMID: 33373936; PMCID: PMC7846816.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans